Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
‘Not sure it was good for anybody’ : Trump reacts to Democrats’ sweep of key races on election night – live
5/11/2025
Second accidental release of prisoner ‘utterly unacceptable’, No 10 says, as Lammy blames system left by Tories – UK politics live
5/11/2025
Two people seriously injured and attacker arrested after car driven into pedestrians and cyclists on French island – Europe live
5/11/2025
WTA Finals tennis : Elena Rybakina v Ekaterina Alexandrova, Iga Swiatek v Amanda Anisimova – live
5/11/2025
Why the anger with Billie Eilish ? You’re not allowed to say what we all know about billionaires … | Zoe Williams
5/11/2025
US supreme court hears oral arguments on legality of Trump imposing tariffs
5/11/2025